Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announc...
Embecta Corp. (EMBC)
Company Research
Source: GlobeNewswire
PARSIPPANY, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and twelve-month periods ended September 30, 2024. "We are pleased to report a strong fourth quarter and end to our fiscal year, as we once again delivered results that exceeded our expectations across key financial metrics. We continued to execute on our strategic priorities, and to date, our significant accomplishments include the successful transition of approximately 98% of our revenue to our own ERP system, shared service capabilities, and distribution infrastructure, with India remaining as our only deferred market. Additionally, the recent launch of our small-pack GLP-1 needles in Germany has gone well, and we are evaluating expanding into other markets," said Devdatt (Dev) Kurdikar, Chief Executive Officer of embecta. Mr. Kurdikar continued: "As our stand-up work nears completi
Show less
Read more
Impact Snapshot
Event Time:
EMBC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EMBC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EMBC alerts
High impacting Embecta Corp. news events
Weekly update
A roundup of the hottest topics
EMBC
News
- embecta to Participate at the 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- Here Is Why Bargain Hunters Would Love Fast-paced Mover Embecta Corp. (EMBC) [Yahoo! Finance]Yahoo! Finance
- Morgan Stanley bullish on medtech in 2025, upgrades 5 stocks [Seeking Alpha]Seeking Alpha
- New Strong Buy Stocks for December 2nd [Yahoo! Finance]Yahoo! Finance
- Embecta Corp. (NASDAQ: EMBC) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $20.00 price target on the stock, up previously from $13.00.MarketBeat
EMBC
Earnings
- 11/26/24 - Beat
EMBC
Sec Filings
- 12/19/24 - Form ARS
- 12/19/24 - Form DEFA14A
- 12/19/24 - Form DEF
- EMBC's page on the SEC website